(Press-News.org) LOS ANGELES (June 15, 2011) – An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.
Patients with newly diagnosed glioblastoma multiforme, the most common and aggressive type of tumor originating in the brain, typically live only 12 to 15 months after diagnosis even with standard treatments: surgery, radiation and chemotherapy.
In this Phase I clinical trial that started in November 2006, 11 of 16 patients (69 percent) were still alive at 32 months (a median analysis time); six of 16 (38 percent) continued to be disease-free; three have gone almost four years and another three have survived more than 2.5 years with no recurrence. Median progression-free survival – the time from treatment to disease recurrence (median progression-free survival) was 16.9 months.
Phase I trials generally address dosage and safety issues. To further evaluate survival statistics, a randomized, multicenter, placebo-controlled Phase II trial has been launched.
ICT-107 targets six antigens found on glioblastoma cells, three of which also are found on cancer stem cells. Those cells widely are believed to be the original source of tumor cells, enabling them to resist treatment and recur. The study revealed that all 16 patients had at least three of the targeted antigens and 75 percent had all six. Patients who had four of the antigens (MAGE-A1, AIM2, gp100 and HER2) had better immune responses and longer progression-free survival rates.
Surasak Phuphanich, MD, director of the Neuro-Oncology Program of the Department of Neurosurgery and the Department of Neurology at Cedars-Sinai, termed another finding significant: levels of a protein associated with cancer stem cells (CD133) decreased in patients who had tumor recurrence after vaccination.
"Previous studies showed an increase in CD133 expression in patients who underwent treatment with radiation and chemotherapy. Our findings suggest that targeting antigens that are highly expressed by cancer stem cells may be a viable strategy for treating patients who have glioblastoma," he said.
Phuphanich participated in other multicenter studies that were presented at the ASCO meetings, including:
"A phase II study of verubulin (MPC-6827) for treatment of subjects with recurrent glioblastoma naïve to treatment with bevacizumab," a poster presentation beginning at 8 a.m. on June 4.
"A phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma," a poster presentation beginning at 8 a.m. on June 4.
"A phase II study of daily afatinib (BIBW 2992) with or without temozolomide (21/28 days) in the treatment of patients with recurrent glioblastoma," an oral platform presentation beginning at 8 a.m. on June 5.
ICT-107 is a product of the biotechnology company ImmunoCellular Therapeutics, Ltd. Keith L. Black, MD, chairman of Cedars-Sinai's Department of Neurosurgery, director of the Maxine Dunitz Neurosurgical Institute and director of the Johnnie L. Cochran, Jr. Brain Tumor Center, is chairman of the company's scientific advisory board. John S. Yu, MD, vice chairman of Neurosurgery, director of the Brain Tumor Center of Excellence, director of Surgical Neuro-Oncology and surgical director of the Gamma Knife Center at Cedars-Sinai, is chief scientific officer, chairman of the board, and shareholder of ImmunoCellular. Certain rights in the dendritic cell vaccine technology and corresponding intellectual property have been exclusively licensed by Cedars-Sinai to ImmunoCellular Therapeutics, including subsequently developed versions of the vaccine investigated in this clinical study.
###
Citation: "Glioma associated antigens associated with prolonged survival in phase I study of ICT-107 for patients with newly diagnosed glioblastoma," (Abstract No. 2042) poster presentation at American Society of Clinical Oncology (ASCO) annual meeting, 8 a.m. to noon CDT, June 4, 2011.
END
People who have duplications in a region of chromosome 16 (16p13.1) that is present in approximately 1 in 1000 individuals have a 12-fold increased risk of thoracic aortic aneurysms leading to a tear in the aorta, or acute aortic dissections. An estimated 10000 people die annually from thoracic aortic aneurysms and dissections (TAAD) in the United States, where TAAD have ranked as high as the 15th leading cause of death. The study, led by genetic researchers at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine, will be published ...
Esteemed dentist in Roswell, GA, Dr. Wyman Martin, is asking patients to complete an exit survey following their appointment in order to enhance the overall patient experience at The Martin Dental Center for Oral Health and Aesthetics. By collecting exit surveys from patients, Dr. Martin can assess any areas in need of improvement and make office adjustments to best accommodate the needs of his patients.
"Dr. Martin has the highest ethics and the most knowledge of any dentist I have ever tried. He is truly committed to the best care possible in a highly professional ...
WHITE PLAINS, N.Y., June 16, 2011 – Fortifying corn masa flour with the B vitamin folic acid could prevent more serious birth defects of the brain and spine in the Hispanic community, according to a March of Dimes commentary published in the American Journal of Public Health.
Fortification of enriched cereal grains such as bread and pasta with folic acid was mandated by the Food & Drug Administration (FDA) beginning in 1998. Since then, the rate of birth defects of the brain and spine known as neural tube defects (NTDs), which include spina bifida and anencephaly, has ...
A bright flash of gamma rays observed March 28 by the Swift satellite may have been the death rattle of a star falling into a massive black hole and being ripped apart, according to a team of astronomers led by the University of California, Berkeley.
When the Swift Gamma Burst Mission spacecraft first detected the flash within the constellation Draco, astronomers thought it was a gamma-ray burst from a collapsing star. On March 31, however, UC Berkeley's Joshua Bloom sent out an email circular suggesting that it wasn't a typical gamma-ray burst at all, but a high-energy ...
COLLEGE PARK, Md. –- Comet Hartley 2, is in a hyperactive class of its own compared to other comets visited by spacecraft, says a University of Maryland-led study published in the June 17 issue of the journal Science.
The comet was visited last fall by NASA's Deep Impact spacecraft during its EPOXI mission. The EPOXI science team's new, in-depth analysis of the images and data taken during the flyby confirms its earlier finding that carbon dioxide is the volatile fuel for Hartley 2's ice-spewing jets.
In-depth analysis of the images and data taken during the flyby ...
Cynthia Hennessey has recently won several million-dollar settlements from work-related injury cases. With over two decades of workers' compensation experience and six years of experience as a registered nurse, Cynthia brings her compassion and expertise to the niche area of workers' compensation cases.
Before becoming an attorney, Cynthia spent six years as a registered nurse working in both the pediatric and adult intensive care areas. This experience led her to develop a compassion for defending those who have been injured at work and ensuring they receive the medical ...
Research led by astronomers at the University of Warwick has confirmed that the flash from one of the biggest and brightest bangs yet recorded by astronomers comes from a massive black hole at the centre of a distant galaxy. The black hole appears to have ripped apart a star that wandered too close, creating a powerful beam of energy that crossed the 3.8 billion light years to Earth.
Their research is published today in the Journal Science in a paper entitled "An Extremely Luminous Panchromatic Outburst from the Nucleus of a Distant Galaxy"
The high energy X-rays and ...
A highly rated phone that Unlock Advantage provides T-Mobile unlock codes for is the T-Mobile G2 with Google. Consumers rave about this mobile device, and they have plenty of reasons.
The T-Mobile G2 with Google is T-Mobile's first Android-powered 4G smartphone. This fine-looking device has an excellent QWERTY keyboard and makes it possible to download apps and search the Internet at incredible speeds. The keyboard has three quick keys that are user-customizable and can each be set to launch any app; this is an awesome feature. When this mobile device is closed, there's ...
Washington, D.C.—Glasses differ from crystals. Crystals are organized in repeating patterns that extend in every direction. Glasses lack this strict organization, but do sometimes demonstrate order among neighboring atoms. New research from Carnegie's Geophysical Laboratory reveals the possibility of creating a metallic glass that is organized on a larger scale. Their results are published June 17 in Science.
Scientists have discovered glasses that demonstrate order among the nearest neighboring atoms, called short-range order, and a slightly wider range of atoms, called ...
Centaurus A, also known as NGC 5128, is well known for its dramatic dusty lanes of dark material. Hubble's observations, using its most advanced instrument, the Wide Field Camera 3, are the most detailed ever made of this galaxy. They have been combined here in a multi-wavelength image that reveals never-before-seen detail in the dusty portion of the galaxy.
As well as features in the visible spectrum, this composite shows ultraviolet light from young stars, and near-infrared light, which lets us glimpse some of the detail otherwise obscured by the dust.
The dark dust ...
